News
10h
Medpage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesCHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
1d
MedPage Today on MSNNovel Oral GLP-1 Agent Cuts A1c, Weight in Early DiabetesCHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) American Diabetes Association (ADA) 85th Scientific Sessions Conference June 20, 2025 8:15 PM ET James Markmann - Corporate Participant Michael ...
The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...
Women who replaced their lunchtime diet beverage with water had greater weight loss and achieved diabetes remission compared ...
Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...
The American Diabetes Association has established standards of care for diabetes patients in the hospital setting.
The new guidelines are intended to “enhance some of the health behaviors that are recommended by all of the leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results